{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:18:54Z","timestamp":1760865534896},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T00:00:00Z","timestamp":1237507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00535-009-0023-0","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T05:39:53Z","timestamp":1237441193000},"page":"476-482","source":"Crossref","is-referenced-by-count":14,"title":["Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?"],"prefix":"10.1007","volume":"44","author":[{"given":"Marilena","family":"Durazzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Niro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Premoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Rosa","family":"Rizzotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Musso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Cassader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarosa","family":"Floreani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,20]]},"reference":[{"key":"23_CR1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2006.03104.x","volume":"24","author":"A Floreani","year":"2006","unstructured":"Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, et al. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther. 2006;24:1051\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"23_CR2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-003-1228-z","volume":"46","author":"M Fasshauer","year":"2003","unstructured":"Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46:1594\u2013603.","journal-title":"Diabetologia"},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(88)90006-2","volume":"2","author":"Y Muto","year":"1988","unstructured":"Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 1988;2:72\u20134.","journal-title":"Lancet"},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-8278(99)80060-9","volume":"30","author":"H Zylberberg","year":"1999","unstructured":"Zylberberg H, Rimaniol AC, Pol S, Masson A, De Groote D, Berthelot P, et al. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol. 1999;30:185\u20139.","journal-title":"J Hepatol"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1568-9972(03)00017-X","volume":"2","author":"D Vergani","year":"2003","unstructured":"Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Autoimmun Rev. 2003;2:241\u20137.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"23_CR6","first-page":"7","volume":"2","author":"JM Friedman","year":"1997","unstructured":"Friedman JM. Leptin, leptin receptors and the control of body weight. Eur J Med Res. 1997;2(1):7\u201313.","journal-title":"Eur J Med Res"},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1210\/en.2005-0248","volume":"146","author":"JP McGillis","year":"2005","unstructured":"McGillis JP. White adipose tissue, inert no more!. Endocrinology. 2005;146:2154\u20136.","journal-title":"Endocrinology"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/cimm.1999.1594","volume":"199","author":"C Martin-Romero","year":"2000","unstructured":"Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000;199:15\u201324.","journal-title":"Cell Immunol"},{"key":"23_CR9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/gast.2002.32995","volume":"122","author":"K Ikejima","year":"2002","unstructured":"Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology. 2002;122:1399\u2013410.","journal-title":"Gastroenterology"},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/jhep.2001.26518","volume":"34","author":"K Ikejima","year":"2001","unstructured":"Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology. 2001;34:288\u201397.","journal-title":"Hepatology"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-7-17","volume":"7","author":"S Manolakopoulos","year":"2007","unstructured":"Manolakopoulos S, Bethanis S, Liapi C, Stripeli F, Sklavos P, Margeli A, et al. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study. BMC Gastroenterol. 2007;7:17.","journal-title":"BMC Gastroenterol"},{"key":"23_CR12","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789\u201395.","journal-title":"J Immunol"},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2006-2614","volume":"92","author":"AJ Hanley","year":"2007","unstructured":"Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in non-diabetic Hispanic and African Americans. J Clin Endocrinol Metab. 2007;92:2665\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"23_CR14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2337\/db06-1580","volume":"56","author":"KK Cheng","year":"2007","unstructured":"Cheng KK, Lam KS, Wang Y, Yu H, Carling D, Wu D, et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes. 2007;56:1387\u201394.","journal-title":"Diabetes"},{"key":"23_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380:24\u201330.","journal-title":"Clin Chim Acta"},{"key":"23_CR16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.106.666941","volume":"115","author":"L Tao","year":"2007","unstructured":"Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, et al. Adiponectin cardioprotection after myocardial ischemia\/reperfusion involves the reduction of oxidative\/nitrative stress. Circulation. 2007;115:1408\u201316.","journal-title":"Circulation"},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/j.1572-0241.2005.00297.x","volume":"100","author":"G Musso","year":"2005","unstructured":"Musso G, Gambino R, Biroli G, Carello M, Fag\u00e0 E, Pacini G, et al. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2005;100:2438\u201346.","journal-title":"Am J Gastroenterol"},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20896","volume":"42","author":"G Musso","year":"2005","unstructured":"Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fag\u00e0 E, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology. 2005;42:1175\u201383.","journal-title":"Hepatology"},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2265.2006.02527.x","volume":"64","author":"G Targher","year":"2006","unstructured":"Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, et al. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin Endocrinol. 2006;64:679\u201383.","journal-title":"Clin Endocrinol"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbrc.2004.08.145","volume":"323","author":"AM Wolf","year":"2004","unstructured":"Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1572-0241.2006.00848.x","volume":"101","author":"E Tsochatzis","year":"2006","unstructured":"Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. The evolving role of leptin and adiponectin in chronic liver disease. Am J Gastroenterol. 2006;101:2629\u201340.","journal-title":"Am J Gastroenterol"},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"23_CR23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/dmrr.561","volume":"21","author":"S Bo","year":"2005","unstructured":"Bo S, Gentile L, Ciccone G, Baldi C, Benini L, Dusio F, et al. The metabolic syndrome and high C-reactive protein: prevalence and difference by sex in a southern-european population-based cohort. Diabetes Metab Res Rev. 2005;21:515\u201324.","journal-title":"Diabetes Metab Res Rev"},{"key":"23_CR24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"issue":"1","key":"23_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1440-1746.2006.04757.x","volume":"23","author":"S Kakizaki","year":"2008","unstructured":"Kakizaki S, Sohara N, Yamazaki Y, Horiguchi N, Kanda D, Kabeya K, et al. Elevated plasma resistin concentrations in patients with liver cirrhosis. J Gastroenterol Hepatol. 2008;23(1):73\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"23_CR26","first-page":"2","volume":"2","author":"AS Petrides","year":"1994","unstructured":"Petrides AS. Liver disease and diabetes mellitus. Diabetes Rev. 1994;2:2\u201318.","journal-title":"Diabetes Rev"},{"key":"23_CR27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jhep.2005.05.030","volume":"43","author":"JR Jonsson","year":"2005","unstructured":"Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, Clouston AD, et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol. 2005;43:929\u201336.","journal-title":"J Hepatol"},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1152\/ajpendo.00494.2003","volume":"287","author":"UJ Tietge","year":"2004","unstructured":"Tietge UJ, Boker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab. 2004;287:E82\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2796.2005.01543.x","volume":"258","author":"S Kaser","year":"2005","unstructured":"Kaser S, Moschen A, Kaser A, Ludwiczek O, Ebenbichler CF, Vogel W, et al. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med. 2005;258:274\u201380.","journal-title":"J Intern Med"},{"key":"23_CR30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1478-3231.2004.0986.x","volume":"25","author":"N Sohara","year":"2005","unstructured":"Sohara N, Takagi H, Kakizaki S, Sato K, Mori M. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels. Liver Int. 2005;25:28\u201332.","journal-title":"Liver Int"},{"key":"23_CR31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2004.12.024","volume":"42","author":"F Tacke","year":"2005","unstructured":"Tacke F, Wustefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol. 2005;42:666\u201373.","journal-title":"J Hepatol"},{"key":"23_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1572-0241.2008.01888.x","volume":"103","author":"A Floreani","year":"2008","unstructured":"Floreani A, Variola A, Niro G, Premoli A, Baldo V, Gambino R, et al. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol. 2008;103:1\u20137.","journal-title":"Am J Gastroenterol"},{"key":"23_CR33","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1046\/j.1523-1755.63.s84.49.x","volume":"84","author":"C Zoccali","year":"2003","unstructured":"Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl. 2003;84:S98\u2013102.","journal-title":"Kidney Int Suppl"},{"key":"23_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2007.02.023","volume":"47","author":"CK Hui","year":"2007","unstructured":"Hui CK, Zhang HY, Lee NP, Chan W, Yueng YH, Leung KW, et al. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J Hepatol. 2007;47:191\u2013202.","journal-title":"J Hepatol"},{"key":"23_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2893.2007.00850.x","volume":"14","author":"D Siagris","year":"2007","unstructured":"Siagris D, Vafiadis G, Michalaki M, Lekkou A, Starakis I, Makri M, et al. Serum adiponectin in chronic hepatitis C and B. J Viral Hep. 2007;14:577\u201383.","journal-title":"J Viral Hep"},{"key":"23_CR36","first-page":"1","volume":"30","author":"E Tsochatzis","year":"2008","unstructured":"Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, et al. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand J Gastroenterol. 2008;30:1\u20139.","journal-title":"Scand J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-009-0023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-009-0023-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-009-0023-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T22:03:07Z","timestamp":1710194587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-009-0023-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,20]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s00535-009-0023-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,20]]}}}